|
LRRC59 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.958500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.261000E-03 |
| Normal-vs-Stage2 |
5.344200E-01 |
| Normal-vs-Stage3 |
1.554990E-04 |
| Normal-vs-Stage4 |
2.11130000005166E-06 |
| Stage1-vs-Stage2 |
5.321800E-02 |
| Stage1-vs-Stage3 |
1.054570E-01 |
| Stage1-vs-Stage4 |
4.976600E-03 |
| Stage2-vs-Stage3 |
4.603200E-03 |
| Stage2-vs-Stage4 |
5.017700E-04 |
| Stage3-vs-Stage4 |
2.717000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.355900E-04 |
| Normal-vs-AfricanAmerican |
7.431800E-02 |
| Normal-vs-Asian |
1.161900E-03 |
| Caucasian-vs-AfricanAmerican |
5.978000E-01 |
| Caucasian-vs-Asian |
6.236800E-01 |
| AfricanAmerican-vs-Asian |
4.156200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.398300E-04 |
| Normal-vs-Female |
3.220800E-03 |
| Male-vs-Female |
1.429790E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.823980E-02 |
| Normal-vs-Age(41-60Yrs) |
9.78249999999958E-05 |
| Normal-vs-Age(61-80Yrs) |
4.358900E-03 |
| Normal-vs-Age(81-100Yrs) |
4.273600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.571800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.912600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.362800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.192400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.118200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.148200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.218400E-01 |
| Classical-VS-Follicular |
2.517600E-01 |
| Classical-VS-Other |
1.253390E-01 |
| Classical-VS-Normal |
7.600200E-04 |
| Tall-VS-Follicular |
1.173440E-01 |
| Tall-VS-Other |
4.457600E-01 |
| Tall-VS-Normal |
1.641410E-03 |
| Follicular-VS-Other |
1.195030E-01 |
| Follicular-VS-Normal |
7.232300E-02 |
| Other-VS-Normal |
4.619500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.738500E-03 |
| Normal-vs-N1 |
4.96309999997724E-06 |
| N0-vs-N1 |
1.785590E-02 |
|
|
